Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Alcolea

Showing results (61-70 of 241) with videos related to

Pageof 25
Sort By:
Frontiers in Neurology|February 4, 2022
Pathophysiological Underpinnings of Extra-Motor Neurodegeneration in Amyotrophic Lateral Sclerosis: New Insights From Biomarker StudiesDavid Reyes-Leiva, Oriol Dols-Icardo, Sonia Sirisi, et al.
Journal of Alzheimer'S Disease : JAD|May 21, 2017
Diagnostic and Prognostic Value of the Combination of Two Measures of Verbal Memory in Mild Cognitive Impairment due to Alzheimer's DiseaseIsabel Sala, Ignacio Illán-Gala, Daniel Alcolea, et al.
Alzheimer'S Research & Therapy|February 25, 2025
Evaluation of cerebrospinal fluid levels of VAMP-2 and SNAP-25 in a dementia with Lewy bodies clinical cohort stratified by Alzheimer's pathophysiological biomarkersAlba Cervantes González, Julie Goossens, Elena Vera Campuzano, et al.
Journal of Alzheimer'S Disease : JAD|March 26, 2013
The AD-CSF-index discriminates Alzheimer's disease patients from healthy controls: a validation studyJose L Molinuevo, Juan Domingo Gispert, Bruno Dubois, et al.
The Journal of Clinical Endocrinology and Metabolism|January 8, 2026
Cerebrospinal Fluid and Plasma Leptin Dynamics Following Bariatric Surgery in WomenAdriana Pané, Laura Videla, Judith Viaplana, et al.
Journal of Alzheimer'S Disease : JAD|October 9, 2010
The effect of MAPT H1 and APOE ε4 on transition from mild cognitive impairment to dementiaLluís Samaranch, Sebastián Cervantes, Ana Barabash, et al.
Journal of Neuromuscular Diseases|April 11, 2023
Full-Length SMN Transcript in Extracellular Vesicles as Biomarker in Individuals with Spinal Muscular Atrophy Type 2 Treated with NusinersenSelena Trifunov, Daniel Natera-de Benito, Laura Carrera-García, et al.
Journal of Alzheimer'S Disease : JAD|January 7, 2017
A Common Variant in the MC1R Gene (p.V92M) is associated with Alzheimer's Disease RiskGemma Tell-Marti, Joan Anton Puig-Butille, Miriam Potrony, et al.
Alzheimer'S Research & Therapy|February 13, 2025
Plasma Hepcidin as a potential informative biomarker of Alzheimer disease and vascular dementiaConstance Delaby, Daniel Alcolea, Germain Busto, et al.
Oncotarget|December 30, 2017
Weight loss in the healthy elderly might be a non-cognitive sign of preclinical Alzheimer's diseaseAmanda Jimenez, Jordi Pegueroles, María Carmona-Iragui, et al.
Pageof 25

Showing results (61-70 of 241) with videos related to

Sort By:
Pageof 25
Frontiers in Neurology|February 4, 2022
Pathophysiological Underpinnings of Extra-Motor Neurodegeneration in Amyotrophic Lateral Sclerosis: New Insights From Biomarker StudiesDavid Reyes-Leiva, Oriol Dols-Icardo, Sonia Sirisi, et al.
Journal of Alzheimer'S Disease : JAD|May 21, 2017
Diagnostic and Prognostic Value of the Combination of Two Measures of Verbal Memory in Mild Cognitive Impairment due to Alzheimer's DiseaseIsabel Sala, Ignacio Illán-Gala, Daniel Alcolea, et al.
Alzheimer'S Research & Therapy|February 25, 2025
Evaluation of cerebrospinal fluid levels of VAMP-2 and SNAP-25 in a dementia with Lewy bodies clinical cohort stratified by Alzheimer's pathophysiological biomarkersAlba Cervantes González, Julie Goossens, Elena Vera Campuzano, et al.
Journal of Alzheimer'S Disease : JAD|March 26, 2013
The AD-CSF-index discriminates Alzheimer's disease patients from healthy controls: a validation studyJose L Molinuevo, Juan Domingo Gispert, Bruno Dubois, et al.
The Journal of Clinical Endocrinology and Metabolism|January 8, 2026
Cerebrospinal Fluid and Plasma Leptin Dynamics Following Bariatric Surgery in WomenAdriana Pané, Laura Videla, Judith Viaplana, et al.
Journal of Alzheimer'S Disease : JAD|October 9, 2010
The effect of MAPT H1 and APOE ε4 on transition from mild cognitive impairment to dementiaLluís Samaranch, Sebastián Cervantes, Ana Barabash, et al.
Journal of Neuromuscular Diseases|April 11, 2023
Full-Length SMN Transcript in Extracellular Vesicles as Biomarker in Individuals with Spinal Muscular Atrophy Type 2 Treated with NusinersenSelena Trifunov, Daniel Natera-de Benito, Laura Carrera-García, et al.
Journal of Alzheimer'S Disease : JAD|January 7, 2017
A Common Variant in the MC1R Gene (p.V92M) is associated with Alzheimer's Disease RiskGemma Tell-Marti, Joan Anton Puig-Butille, Miriam Potrony, et al.
Alzheimer'S Research & Therapy|February 13, 2025
Plasma Hepcidin as a potential informative biomarker of Alzheimer disease and vascular dementiaConstance Delaby, Daniel Alcolea, Germain Busto, et al.
Oncotarget|December 30, 2017
Weight loss in the healthy elderly might be a non-cognitive sign of preclinical Alzheimer's diseaseAmanda Jimenez, Jordi Pegueroles, María Carmona-Iragui, et al.
Pageof 25